Genome Medical Stock
Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.
Sign up today and learn more about Genome Medical Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Genome Medical Stock
Genome Medical is a national telegenomics technology, services, and strategy company bringing genomic medicine to everyday care. Through its nationwide network of genetic specialists and an efficient Genome Care DeliveryTM technology platform, we provide expert virtual genetic care for individuals and their families to improve health and well-being. They also help health care providers and their patients navigate the rapidly expanding field of genetics and utilize test results to understand the risk for disease, accelerate disease diagnosis, make informed treatment decisions and lower the cost of care. The company was founded in 2016 and is based in South San Francisco, California, United States.
Funding History
| November 2016 | $400K |
|---|---|
| May 2017 | $12.0M |
| January 2018 | $11.0M |
| June 2019 | $23.0M |
| July 2020 | $325K |
| July 2020 | $14.0M |
| August 2021 | $60.0M |
Management
Co-Founder & CEO
Lisa Alderson
Co-Founder
Robert Green
Board Member
Stephen Bloch
Board of Directors
Jill Davies
Board Observer
Keith Figlioli
Echo Health Ventures, Board Member Genome Medical
Jessica Zeaske
Board of Directors
Shaun Rodriguez
CMO
Steven Bleyl
CSO & VP
Hunt Willard
Board Member
Jessica Zeaske
Board of Directors
Eli Casdin
Co-Founder & Chairman
Randy Scott
Board Member | Chair Compensation | Audit | Committee | Start-Up Investor | Genome | Medicine
Timothy F.Howe
Advisor
Todd Meyerrose
Board Member
Nicholas J. Naclerio
Press
biospace - Sep, 20 2022
Genome Medical and Pierian Announce Collaboration to Optimize Genomic Testing Programsmobihealthnews - Aug, 31 2021
Genome Medical scoops up telegenetic counseling platform GeneMatters, raises $60M in Series Cbizjournals - Aug, 30 2021
Minneapolis-based GeneMatters acquired by Genome Medicalbit - Nov, 20 2020
Genome Medical Reaches 90 Million Covered Lives in U.S.fiercebiotech - Jul, 13 2020
Telegenomics provider Genome Medical raises $14M, plus Samsung Catalyst partnershipgenomeweb - Jul, 2 2020
Genome Medical Raises $14M in Extended Series B Financingvcaonline - Jul, 2 2020
Venture Capital Database 2020 Now Available!medcitynews - Jul, 2 2020
‘Telegenomics’ startup Genome Medical raises another $14Mprnewswire - Jan, 24 2020
Genome Medical Adds Population Genomics Offering to Enable Increased Access for Individuals Nationwidefiercebiotech - Nov, 1 2019
Genome Medical expands its telegenetics work into personalized care coordinationnanalyze - Oct, 19 2019
9 Genomics Startups for Investors to Watchbetakit - Jun, 22 2019
H|T: The Healthtech Times – Canada’s new healthtech fundfiercebiotech - Jun, 13 2019
Genome Medical nets $23M to grow its telegenomics service platformbusinesswire - Apr, 4 2019
PerkinElmer Genomics Introduces Physician-Ordered Genetic Screening Test for Proactive Health ManagementEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
